10/17/22: Long-dreaded countdown at AbbVie

In just three months, AbbVie’s leading product, Humira, will face biosimilar competition in the U.S. for the first time. Crain’s health care reporter Katherine Davis talks with host Amy Guth about what the future might look like for the drugmaker. Plus: Mariano's parent to buy Jewel-Osco owner, AT&T cuts deal in Madigan case as former exec charged, downtown office vacancy inches back up to record high, and Gov. J.B. Pritzker and his challenger Darren Bailey individually met with Crain's editorial board to discuss their respective visions for the state.